AAMC Home   Tomorrow's Doctors Tomorrow's Cures
  Home  Government Affairs   Newsroom   Meetings   Publications Shopping Cart   Site Map    

 

Home

Washington Highlights

Testimony & Correspondence

Top Issues:

 

Education

 

GME & IME Payments

HIPAA

Labor-HHS Appropriations

Research

Teaching Hospitals

Teaching Physicians

Veterans Affairs

Workforce

Government Affairs & Advocacy Site Map

Contact

 

Government Affairs Home > Research > Stem Cell Research

AAMC's Letter to Senators Specter and Harkin on Stem Cell Research Legislation

[The AAMC also has written a letter to President Bush in support of the federal funding of embryonic stem cell research. The Coalition for the Advancement of Medical Research (CAMR) can provide additional information on efforts to maintain federal funding for stem cell research. The Coalition is an organization of universities, scientific and academic societies, patients’ organizations, and other entities that are devoted to ensuring that federal funding will be available for stem cell research using fertilized eggs developed for in vitro fertilization and that the current federal guidelines overseeing the research are retained. The AAMC is a charter member of the Coalition and serves on its board of directors.]

May 17, 2001

The Honorable Arlen Specter
The Honorable Tom Harkin
United States Senate
Washington, DC 20510

Dear Senators Specter and Harkin:

On behalf of the Association of American Medical Colleges, I am pleased to endorse your legislation, S. 723, The Stem Cell Research Act of 2001. The Association believes that the current National Institutes of Health (NIH) guidelines, which enable scientists to conduct stem cell research under strict federal oversight and standards, should remain in effect, as your legislation would ensure. The discovery of human pluripotent stem cells is a significant research advance and Federal support to American researchers is essential to translate this discovery into innovative therapies for a range of serious and intractable diseases.

The therapeutic potential of pluripotent stem cells is remarkable - arguably more remarkable than any previous advance in the history of medical science. These cells have the unique potential to differentiate into any human cell type and offer real hope of life-affirming treatments for diabetes, damaged heart tissue, arthritis, Parkinson's, Alzheimer's, ALS and spinal cord injuries, to name but a few examples. There is also the possibility that these cells could be used to create more complex, vital organs, such as kidneys, livers, or even hearts.

We recognize the significant ethical issues that are raised about embryonic stem cell research and we respect the view of those who oppose such research, including some in our own medical school community. However, the AAMC is persuaded otherwise by what we believe is an equally compelling ethical consideration, namely, that it would be tragic to waste the unique potential afforded by embryonic stem cells, destined to be discarded in any case, to alleviate human suffering and enhance the quality of human life.

Therefore, we support your legislation, S. 723, which would allow the NIH to use federal funding to derive stem cells and use them in research. We look forward to working with you on any and all legislative initiatives that would enable NIH to fund human embryonic stem cell research.

Once again, thank you for your leadership on this issue, and we look forward to working with you this year to enact human embryonic stem cell research legislation.

Sincerely

Jordan J. Cohen, M.D.
President, AAMC 

This page contains documents in Portable Document Format (PDF). The Adobe Acrobat® Reader® is required to view PDF documents. Download Acrobat® Reader®.

Contact Us    © 1995-2008 AAMC    Terms and Conditions    Privacy Statement